Quarterly report · Q2
6856.TEDINET S100P17D
Period2022-01-01 → 2022-06-30
Filed2022-08-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥115.0bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥224.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥101.3bn | 2021-01-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥16.3bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥13.1bn | 2021-01-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥16.8bn | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥32.0bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.0bn | 2021-01-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥16.8bn | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥13.0bn | 2021-01-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥11.2bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21.3bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥8.7bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥11.2bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥8.7bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥398.4bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥371.6bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥349.0bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥173.8bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥167.1bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥224.6bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥204.5bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥191.6bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥140.0bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥135.0bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥139.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥133.9bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥122.0bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥114.2bn | at 2020-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥10.3bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥15.8bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥14.7bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.9bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥6.9bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.0bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.1bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥266.31 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥130.72 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥505.05 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥207.24 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥114.81 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥264.93 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥502.46 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥206.2 | 2021-01-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 56.2% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.8% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.7% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥25.7bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥25.7bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥1.8bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥13.7bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥13.7bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥162m |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥10.2bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥10.2bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥638m |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥16.0bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥16.0bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥765m |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥49.4bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥49.4bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥16.8bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥24.9bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥24.9bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | segment profit | 2021-01-01 → 2021-06-30 | −¥1.2bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥12.9bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥12.9bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥326m |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥1.1bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥13.4bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥13.4bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥464m |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥40.0bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥40.0bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥12.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 560
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes and accounts payable trade | CurrentQuarterInstant | 32539000000 | JPY |
| Short term loans payable | Prior1YearInstant | 25107000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 24361000000 | JPY |
| Accounts payable other | Prior1YearInstant | 16407000000 | JPY |
| Accounts payable other | CurrentQuarterInstant | 17133000000 | JPY |
| Income taxes payable | Prior1YearInstant | 7632000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 6303000000 | JPY |
| Advances received | Prior1YearInstant | 14308000000 | JPY |
| Advances received | CurrentQuarterInstant | - | JPY |
| Contract liabilities | Prior1YearInstant | - | JPY |
| Contract liabilities | CurrentQuarterInstant | 18413000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 1137000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 951000000 | JPY |
| Provision for directors bonuses | Prior1YearInstant | - | JPY |
| Provision for directors bonuses | CurrentQuarterInstant | 383000000 | JPY |
| Provision for product warranties | Prior1YearInstant | 2630000000 | JPY |
| Provision for product warranties | CurrentQuarterInstant | 2753000000 | JPY |
| Other cl | Prior1YearInstant | 5368000000 | JPY |
| Other cl | CurrentQuarterInstant | 5544000000 | JPY |
| Current liabilities | Prior1YearInstant | 102139000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 108384000000 | JPY |
| Bonds payable | Prior1YearInstant | 30000000000 | JPY |
| Bonds payable | CurrentQuarterInstant | 30000000000 | JPY |
| Long term loans payable | Prior1YearInstant | 25077000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 25285000000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 1731000000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 1407000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 2107000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 2404000000 | JPY |
| Other ncl | Prior1YearInstant | 6036000000 | JPY |
| Other ncl | CurrentQuarterInstant | 6268000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 64953000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 65365000000 | JPY |
| Liabilities | Prior1YearInstant | 167092000000 | JPY |
| Liabilities | CurrentQuarterInstant | 173750000000 | JPY |
| Capital stock | Prior1YearInstant | 12011000000 | JPY |
| Capital stock | CurrentQuarterInstant | 12011000000 | JPY |
| Capital surplus | Prior1YearInstant | 18624000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 18684000000 | JPY |
| Retained earnings | Prior1YearInstant | 166892000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 173913000000 | JPY |
| Treasury stock | Prior1YearInstant | -1323000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -1195000000 | JPY |
| Shareholders equity | Prior1YearInstant | 196204000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 203413000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 5664000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 4615000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 1889000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 15909000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | -69000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |